Standard BioTools Inc. (LAB)

USD 1.99

(-10.18%)

Total Liabilities Summary of Standard BioTools Inc.

  • Standard BioTools Inc.'s latest annual total liabilities in 2023 was 159.86 Million USD , down -66.11% from previous year.
  • Standard BioTools Inc.'s latest quarterly total liabilities in 2024 Q2 was 198.47 Million USD , down -0.94% from previous quarter.
  • Standard BioTools Inc. reported annual total liabilities of 471.77 Million USD in 2022, up 161.2% from previous year.
  • Standard BioTools Inc. reported annual total liabilities of 180.61 Million USD in 2021, down -2.74% from previous year.
  • Standard BioTools Inc. reported quarterly total liabilities of 192.2 Million USD for 2024 Q3, down -3.16% from previous quarter.
  • Standard BioTools Inc. reported quarterly total liabilities of 200.35 Million USD for 2024 Q1, up 25.33% from previous quarter.

Annual Total Liabilities Chart of Standard BioTools Inc. (2023 - 2001)

Historical Annual Total Liabilities of Standard BioTools Inc. (2023 - 2001)

Year Total Liabilities Total Liabilities Growth
2023 159.86 Million USD -66.11%
2022 471.77 Million USD 161.2%
2021 180.61 Million USD -2.74%
2020 185.7 Million USD 67.0%
2019 111.2 Million USD -51.97%
2018 231.53 Million USD -9.7%
2017 256.41 Million USD 1.29%
2016 253.16 Million USD -1.17%
2015 256.16 Million USD -0.38%
2014 257.14 Million USD 1198.88%
2013 19.79 Million USD 51.41%
2012 13.07 Million USD -41.7%
2011 22.42 Million USD -89.52%
2010 213.96 Million USD 3.98%
2009 205.77 Million USD 7.91%
2008 190.69 Million USD 3.02%
2007 185.1 Million USD 29.75%
2006 142.66 Million USD 0.0%
2001 -54.1 Million USD 0.0%

Peer Total Liabilities Comparison of Standard BioTools Inc.

Name Total Liabilities Total Liabilities Difference
Bionano Genomics, Inc. 118.24 Million USD -35.196%
Prenetics Global Limited 44.01 Million USD -263.22%
Star Equity Holdings, Inc. 21.67 Million USD -637.555%
CareDx, Inc 223.28 Million USD 28.404%
Exact Sciences Corporation 3.32 Billion USD 95.194%
Exagen Inc. 34.25 Million USD -366.759%
Inotiv, Inc. 588.04 Million USD 72.814%
Guardant Health, Inc. 1.62 Billion USD 90.179%
Biodesix, Inc. 94.51 Million USD -69.141%
BioNexus Gene Lab Corp. 1.74 Million USD -9077.406%
Precipio, Inc. 3.67 Million USD -4253.622%
iSpecimen Inc. 6.07 Million USD -2530.198%
Natera, Inc. 691.79 Million USD 76.891%
Aspira Women's Health Inc. 8.62 Million USD -1753.078%
23andMe Holding Co. 206.64 Million USD 22.639%
Castle Biosciences, Inc. 86.54 Million USD -84.725%
Personalis, Inc. 95.65 Million USD -67.121%
Aclaris Therapeutics, Inc. 40.22 Million USD -297.417%
Applied DNA Sciences, Inc. 8.77 Million USD -1720.959%
OpGen, Inc. 13.44 Million USD -1089.13%
T2 Biosystems, Inc. 62.83 Million USD -154.428%
Myriad Genetics, Inc. 312.9 Million USD 48.909%
ICON Public Limited Company 7.74 Billion USD 97.937%
NeoGenomics, Inc. 739.69 Million USD 78.388%
Star Equity Holdings, Inc. 21.67 Million USD -637.555%
IDEXX Laboratories, Inc. 1.77 Billion USD 90.996%
RadNet, Inc. 2.07 Billion USD 92.289%
MDxHealth SA 121.92 Million USD -31.119%
Psychemedics Corporation 6.59 Million USD -2322.931%
Illumina, Inc. 4.36 Billion USD 96.338%
Check-Cap Ltd. 1.33 Million USD -11919.925%
Twist Bioscience Corporation 152.97 Million USD -4.507%
DarioHealth Corp. 38.24 Million USD -318.002%
Fulgent Genetics, Inc. 139.82 Million USD -14.334%
Sera Prognostics, Inc. 25.28 Million USD -532.302%
ENDRA Life Sciences Inc. 1.09 Million USD -14497.45%
OPKO Health, Inc. 622.47 Million USD 74.318%
Medpace Holdings, Inc. 1.09 Billion USD 85.439%
Neogen Corporation 1.44 Billion USD 88.898%
Intelligent Bio Solutions Inc. 5.59 Million USD -2756.94%
Prenetics Global Limited 44.01 Million USD -263.22%
Mainz Biomed B.V. 12.15 Million USD -1214.701%
bioAffinity Technologies, Inc. 3.36 Million USD -4648.987%
Trinity Biotech plc 83.38 Million USD -91.721%
Neuronetics, Inc. 81.64 Million USD -95.815%
Sotera Health Company 2.68 Billion USD 94.05%
bioAffinity Technologies, Inc. 3.36 Million USD -4648.987%